Search
for
Sort by
Research 541–570 of 1000+
- IMPACTO DA VACINAÇÃO CONTRA COVID-19 NO ESTADO DO MARANHÃO
- Comparison of the Diagnoses of Dermatology Patients in COVID-19 Period with Previous Year: What Has Changed?
- Blood group O and post-COVID-19 syndrome
- Referee report. For: Practices, awareness, and perception towards home-based COVID-19 management among the general population in Mangalore city in south India [version 2; peer review: 1 approved, 1 approved with reservations]
- Referee report. For: Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic [version 2; peer review: 1 approved]
- Red nail bands in conjunction with telogen effluvium as a post‐COVID‐19 phenomenon
- Another year in the grip of COVID‐19 with slow recovery
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Systematic Review—The Potential Implications of Different Platelet-Rich Plasma (PRP) Concentrations in Regenerative Medicine for Tissue Repair
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Recurrence of cutaneous T‐cell lymphoma post viral vector COVID‐19 vaccination
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)
- Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Pityriasis rosea as a leading manifestation of COVID‐19 infection
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Longitudinal Assessment of the Prevalence of Actinic Keratosis and Extensive Risk Factor Evaluation: An Update from the Rotterdam Study
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID‐19
- Efficacy of QR678 Neo<sup>®</sup> hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Androgens’ Role in Severity and Mortality Rates of COVID-19